Evidence map›Paper›PMID 35627870›Full record

ArticleInternational journal of environmental research and public health2022

Shorter Incubation Period among COVID-19 Cases with the BA.1 Omicron Variant.

Hideo Tanaka, Tsuyoshi Ogata, Toshiyuki Shibata, Hitomi Nagai, Yuki Takahashi, Masaru Kinoshita, Keisuke Matsubayashi, Sanae Hattori, Chie Taniguchi

Abstract read
In one paragraph

Article in International journal of environmental research and public health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed, 5 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 5 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Article
  7. Article
  8. Observational
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Hideo TanakaPublic Health Center of Neyagawa City, Neyagawa 572-0838, Japan.
Tsuyoshi OgataItako Public Health Center of Ibaraki Prefectural Government, Itako 311-2422, Japan.ORCID 0000-0002-3261-888X
Toshiyuki ShibataPublic Health Center of Suita City, Suita 564-0072, Japan.
Hitomi NagaiIbaraki Public Health Center of Osaka Prefectural Government, Ibaraki 567-8585, Japan.
Yuki TakahashiFujiidera Public Health Center of Osaka Prefectural Government, Fujiidera 583-0024, Japan.
Masaru KinoshitaFujiidera Public Health Center of Osaka Prefectural Government, Fujiidera 583-0024, Japan.
Keisuke MatsubayashiPublic Health Center of Suita City, Suita 564-0072, Japan.
Sanae HattoriIbaraki Prefetural Office, Mito 310-0852, Japan.
Chie TaniguchiCollege of Nursing, Aichi Medical University, Nagakute 480-1195, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We aimed to elucidate the range of the incubation period in patients infected with the SARS-CoV-2 Omicron variant in comparison with the Alpha variant. Contact tracing data from three Japanese public health centers (total residents, 1.06 million) collected following the guidelines of the Infectious Diseases Control Law were reviewed for 1589 PCR-confirmed COVID-19 cases diagnosed in January 2022. We identified 77 eligible symptomatic patients for whom the date and setting of transmission were known, in the absence of any other probable routes of transmission. The observed incubation period was 3.03 ± 1.35 days (mean ± SDM). In the log-normal distribution, 5th, 50th and 95th percentile values were 1.3 days (95% CI: 1.0−1.6), 2.8 days (2.5−3.1) and 5.8 days (4.8−7.5), significantly shorter than among the 51 patients with the Alpha variant diagnosed in April and May in 2021 (4.94 days ± 2.19, 2.1 days (1.5−2.7), 4.5 days (4.0−5.1) and 9.6 days (7.4−13.0), p < 0.001). As this incubation period, mainly of sublineage BA.1, is even shorter than that in the Delta variant, it is thought to partially explain the variant replacement occurring in late 2021 to early 2022 in many countries.

Indexed as

COVID-19Infectious Disease Incubation PeriodSARS-CoV-2Contact TracingHumansJapanAlpha variantcontact tracingCOVID-19incubation periodJapanese Public Health CenterOmicron variantSARS-CoV-2

Identifiers

PMID35627870
PMCPMC9140418

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.